Definition:Behavioural remedy
⚖️ Behavioural remedy is a condition imposed by a competition authority or insurance regulator that requires a company — typically following a merger, acquisition, or finding of anti-competitive conduct — to modify specific business practices rather than divest assets. In the insurance industry, behavioural remedies arise most frequently when consolidation among carriers, brokers, or reinsurers raises concerns about market power, pricing transparency, or access to distribution channels, but regulators determine that a structural break-up or forced divestiture would be disproportionate or impractical.
🔧 Regulators tailor behavioural remedies to the specific competitive harm identified. In an insurance context, a common remedy might require the merged entity to continue offering policies through independent broker panels rather than restricting distribution to proprietary channels, or to maintain open access to claims data and underwriting data systems for third-party participants. Another frequent condition involves commitments to refrain from bundling or tying products — for example, preventing a combined insurer-broker from steering clients exclusively toward affiliated underwriters. Compliance is typically monitored through periodic reporting obligations or the appointment of an independent trustee, and the remedy may have a fixed duration or remain in force indefinitely, depending on the jurisdiction. European competition authorities and the UK's Competition and Markets Authority have both imposed behavioural remedies in notable insurance and broking transactions.
📌 The practical effectiveness of behavioural remedies in insurance markets is a subject of ongoing debate. Proponents argue that they preserve the efficiency gains of consolidation — such as improved capital efficiency, broader product offerings, and enhanced technology platforms — while neutralizing specific competitive risks. Critics counter that behavioural remedies are inherently harder to monitor and enforce than structural remedies like asset divestitures, since they require ongoing supervision of conduct rather than a one-time transaction. For insurance executives and dealmakers, the possibility of behavioural remedies materially shapes due diligence processes and deal structuring: understanding which commitments a regulator may demand helps acquirers model realistic post-merger economics and operational constraints before committing to a transaction.
Related concepts: